Table 1: Demographic and Clinical Characteristics - Rheumatoid_arthritis_&_osteoarthritis
	Total	non-current NSAID use	current NSAID use

1	  561,849 (100.0)	        0 (  .)	  561,849 (100.0)

Grouped age
1	   15,857 (2.8)	        0 (  .)	   15,857 (2.8)
2	   50,553 (9.0)	        0 (  .)	   50,553 (9.0)
3	  140,014 (24.9)	        0 (  .)	  140,014 (24.9)
4	  171,896 (30.6)	        0 (  .)	  171,896 (30.6)
5	  135,846 (24.2)	        0 (  .)	  135,846 (24.2)
6	   47,683 (8.5)	        0 (  .)	   47,683 (8.5)

Male
0	  349,830 (62.3)	        0 (  .)	  349,830 (62.3)
1	  212,019 (37.7)	        0 (  .)	  212,019 (37.7)

Grouped BMI
1	    4,383 (0.8)	        0 (  .)	    4,383 (0.8)
2	  112,732 (20.1)	        0 (  .)	  112,732 (20.1)
3	  186,525 (33.2)	        0 (  .)	  186,525 (33.2)
4	  125,127 (22.3)	        0 (  .)	  125,127 (22.3)
5	   56,542 (10.1)	        0 (  .)	   56,542 (10.1)
6	   30,766 (5.5)	        0 (  .)	   30,766 (5.5)
.	   45,774 (8.1)	        0 (  .)	   45,774 (8.1)

Smoking status
1	  234,271 (41.7)	        0 (  .)	  234,271 (41.7)
2	  252,734 (45.0)	        0 (  .)	  252,734 (45.0)
3	   73,867 (13.1)	        0 (  .)	   73,867 (13.1)
.	      977 (0.2)	        0 (  .)	      977 (0.2)

Smoking status (missing set to non)
1	  235,248 (41.9)	        0 (  .)	  235,248 (41.9)
2	  252,734 (45.0)	        0 (  .)	  252,734 (45.0)
3	   73,867 (13.1)	        0 (  .)	   73,867 (13.1)
.	        0 (0.0)	        0 (  .)	        0 (0.0)

Ethnicity
1	  394,412 (70.2)	        0 (  .)	  394,412 (70.2)
2	    2,962 (0.5)	        0 (  .)	    2,962 (0.5)
3	   26,935 (4.8)	        0 (  .)	   26,935 (4.8)
4	    8,320 (1.5)	        0 (  .)	    8,320 (1.5)
5	    4,689 (0.8)	        0 (  .)	    4,689 (0.8)
.	  124,531 (22.2)	        0 (  .)	  124,531 (22.2)

Index of Multiple Deprivation (IMD)
1	  113,677 (20.2)	        0 (  .)	  113,677 (20.2)
2	  112,361 (20.0)	        0 (  .)	  112,361 (20.0)
3	  112,819 (20.1)	        0 (  .)	  112,819 (20.1)
4	  111,061 (19.8)	        0 (  .)	  111,061 (19.8)
5	  111,931 (19.9)	        0 (  .)	  111,931 (19.9)
.	        0 (0.0)	        0 (  .)	        0 (0.0)

Diabetes Severity
1	  476,668 (84.8)	        0 (  .)	  476,668 (84.8)
2	   63,152 (11.2)	        0 (  .)	   63,152 (11.2)
3	   20,731 (3.7)	        0 (  .)	   20,731 (3.7)
4	    1,298 (0.2)	        0 (  .)	    1,298 (0.2)
.	        0 (0.0)	        0 (  .)	        0 (0.0)

Rheumatoid arthritis/osteoarthritis/both
.	        0 (0.0)	        0 (  .)	        0 (0.0)
1	   30,211 (5.4)	        0 (  .)	   30,211 (5.4)
2	  511,804 (91.1)	        0 (  .)	  511,804 (91.1)
3	   19,834 (3.5)	        0 (  .)	   19,834 (3.5)
.	        0 (0.0)	        0 (  .)	        0 (0.0)



Diagnosed hypertension
1	  208,192 (37.1)	        0 (  .)	  208,192 (37.1)

Heart Failure
1	    6,428 (1.1)	        0 (  .)	    6,428 (1.1)

Other Heart Diseases
1	   14,525 (2.6)	        0 (  .)	   14,525 (2.6)

Diabetes
1	   85,181 (15.2)	        0 (  .)	   85,181 (15.2)

COPD
1	   27,370 (4.9)	        0 (  .)	   27,370 (4.9)

Other Respiratory Diseases
1	   11,199 (2.0)	        0 (  .)	   11,199 (2.0)

Cancer
1	   53,891 (9.6)	        0 (  .)	   53,891 (9.6)

Immunosuppressed (combination algorithm)
1	    6,129 (1.1)	        0 (  .)	    6,129 (1.1)

Chronic kidney disease
1	   39,418 (7.0)	        0 (  .)	   39,418 (7.0)

Osteoarthritis
1	  531,638 (94.6)	        0 (  .)	  531,638 (94.6)

Rheumatoid arthritis
1	   50,045 (8.9)	        0 (  .)	   50,045 (8.9)

Flu vaccine
1	  269,445 (48.0)	        0 (  .)	  269,445 (48.0)

Pneumococcal Vaccine
1	   75,118 (13.4)	        0 (  .)	   75,118 (13.4)

Recent Statin
1	  144,321 (25.7)	        0 (  .)	  144,321 (25.7)

Recent PPIs
1	  240,654 (42.8)	        0 (  .)	  240,654 (42.8)

Recent oral prednisolone
1	   24,282 (4.3)	        0 (  .)	   24,282 (4.3)

Recent hydroxychloroquine
1	   10,933 (1.9)	        0 (  .)	   10,933 (1.9)

Recent Other DMARDs use
1	   27,132 (4.8)	        0 (  .)	   27,132 (4.8)

GP consultation in last year (binary)
1	  540,534 (96.2)	        0 (  .)	  540,534 (96.2)

A&E attendance rate in last year (binary)
1	  104,710 (18.6)	        0 (  .)	  104,710 (18.6)

GP consultation count
Median (IQR)	8 (4-13)	. (.-.)	8 (4-13)
Min, Max	0, 376	., .	0, 376
Age (years)
Median (IQR)	64 (55-72)	. (.-.)	64 (55-72)
Min, Max	18, 110	., .	18, 110
A&E attendance count
Median (IQR)	0 (0-0)	. (.-.)	0 (0-0)
Min, Max	0, 77	., .	0, 77

Median (IQR)	117 (117-117)	. (.-.)	117 (117-117)
Min, Max	1, 117	., .	1, 117
